|
The latest generation of prescription drugs originally developed to help people manage their Type 2 Diabetes have been causing quite a stir for patients, health professionals, and benefit plans. With these drugs approved and being promoted to treat weight loss, plan sponsors are revisiting coverage rules because of the effectiveness and demand for these newer weight-loss drugs.
This presentation discusses key considerations for developing weight loss and Diabetes management programs for your organization. It will include a historical review of GLP-1 medications and what to consider before planning to cover this medication as well as holistic approach to weight management coverage in a plan. Takeaways/Learning Outcomes 1. Understand the history behind glucagon-like peptide-1 or GLP-1 medications and how the current usage trends are impacting plans, as well as ways to better manage the rising utilization and cost of these medications 2. Learn what plan sponsors should consider before deciding to cover anti-obesity medications, including the importance of incorporating behavioral health programs 3. Take away further considerations for all other (non-pharmacy) components of holistic weight loss programs Speakers
Eileen Pincay, R.Ph.
Senior Vice President and National Pharmacy Practice Leader Segal, New York Ms. Pincay has over 20 years of experience in the pharmacy industry, serving in management, clinical and consulting roles. Ms. Pincay assists clients in optimizing benefit design and drug mix and provides consulting services that incorporate advanced data analytics with the latest best-practice guidelines for clinical pharmacy. She has extensive expertise in pharmacy benefit management (PBM), clinical programs, client management and plan design strategy. Prior to Segal, Ms. Pincay served as a Senior Clinical Account Executive and Clinical Director at Express Scripts, where she gained expertise in clinical drug management protocols, formulary consulting and trend management strategies. Ms. Pincay holds a bachelor’s degree of Science in Pharmacy from St. John’s University and is a Board Certified Pharmacist and is licensed in the states of New York and New Jersey. She is frequently asked to speak at various industry events across the country. 
Len Spangher CEBS, MHP
Vice President & Senior Consultant Segal, New York Len Spangher has over 28 years of experience in the consulting industry, over 23 of which are with Segal, focusing on health and welfare benefits design, strategies, and related consulting. Len specializes in wellness program benefit design, health and welfare nondiscrimination testing, and is the administrator of, and lead author of publications regarding, Segal’s College and University Benefits Study (CUBS) Higher Education employee benefits database. Prior to joining Segal, Len worked in an actuarial capacity at Buck Consultants. Len has spoken at various ISCEBS and SHRM local, state and national events. Len holds a Bachelor’s Degree in Actuarial Science and a Master’s Degree in Management, both from New Jersey Institute of Technology. |
Date: Wednesday, October 9, 2024 Time: 12:00 - 1:15 pm CST - Presentation and Q & A 1:00 - 2:15 pm EST - Presentation and Q & A Location: Virtual Only Cost: Free - ISCEBS Chapter Members $20 - Non-ISCEBS Members Registration: Please click here to register by 10/2. Non-members will be led to the payment page. Members can disregard the payment page. Refund Policy: Please contact the chapter no later than one day before the event to receive a refund. Questions: Please email [email protected].
|
